Related Experiment Video
Updated: Jul 18, 2025

Microsatellite DNA Genotyping and Flow Cytometry Ploidy Analyses of Formalin-fixed Paraffin-embedded Hydatidiform Molar Tissues
Published on: October 20, 2019
Prenatal Diagnosis of Mucopolysaccharidosis-Plus Syndrome (MPSPS)
Viktoriia Sofronova1,2, Lyutsiya Gotovtseva3, Anastasia Danilova1
1Laboratory of Molecular Medicine and Human Genetics, North-Eastern Federal University, 677013 Yakutsk, Russia.
Abstract:
Mucopolysaccharidosis-plus syndrome (MPSPS) is an autosomal-recessive disorder caused by c.1492C>T (p.R498W) in the VPS33A gene. MPSPS is a severe disorder that causes a short lifespan in patients. Currently, there is no specific treatment for patients. The Yakut population is more prone to this disease than others. Diagnosing MPSPS relies on clinical manifestations, and genetic testing (GT) is used to confirm the diagnosis. In this research, we examined two pregnancy cases, one of which involved a prenatal diagnosis for MPSPS. Notably, neither pregnant woman had a known family history of the disorder. During their pregnancies, both women underwent prenatal ultrasonography, which revealed increased prenasal thickness during the second trimester. In the first case, ultrasonography indicated increased prenasal thickness in the second trimester, but a definitive diagnosis was not made at that time. The patient was eventually diagnosed with MPSPS at 11 months of age. On the contrary, in the second case, GT uncovered that the parents were carriers of MPSPS. Consequently, a placental biopsy was performed, leading to an early diagnosis of MPSPS. This study emphasizes the importance of ultrasonography findings in prenatal MPSPS diagnosis. Combining ultrasonography with GT can be a valuable approach to confirming MPSPS at an early stage, allowing for the appropriate planning of delivery methods and medical care. Ultimately, this comprehensive approach can significantly enhance the quality of life of both affected patients and their parents.
Insights
Mucopolysaccharidosis-plus syndrome (MPSPS) diagnosis can be improved with prenatal ultrasonography and genetic testing. Early detection of MPSPS enables better planning for affected infants and families.
Area of Science:
- Genetics
- Medical Diagnostics
- Prenatal Care
Background:
- Mucopolysaccharidosis-plus syndrome (MPSPS) is a severe autosomal-recessive disorder caused by mutations in the VPS33A gene, leading to a shortened lifespan.
- Currently, no specific treatments exist for MPSPS, highlighting the need for early diagnosis and management.
- The Yakut population exhibits a higher prevalence of MPSPS, underscoring the importance of targeted screening.
Observation:
- This study investigated two pregnancies, one with a prenatal diagnosis of MPSPS, neither with a prior family history.
- Prenatal ultrasonography in both cases revealed increased prenasal thickness during the second trimester.
- One case received a late diagnosis at 11 months, while the other achieved early diagnosis via genetic testing and placental biopsy.
Findings:
- Prenatal ultrasonography, particularly the detection of increased prenasal thickness, is a crucial indicator for potential MPSPS diagnosis.
- Combining ultrasonography with genetic testing (GT) facilitates early and accurate prenatal diagnosis of MPSPS.
- Early diagnosis through integrated diagnostic approaches allows for timely intervention and management strategies.
Implications:
- Early MPSPS diagnosis via combined ultrasonography and GT is vital for optimizing delivery planning and neonatal care.
- This comprehensive diagnostic approach can significantly improve the quality of life for infants with MPSPS and their families.
- Further research into MPSPS genetics and early detection methods is warranted to improve patient outcomes.
More Related Videos
08:51Profiling of Permethylated Mucin O-glycans Using Matrix-assisted Laser Desorption/Ionization Time-of-flight Mass Spectrometry
Published on: June 20, 2025
05:58Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format
Published on: August 20, 2018
Related Concept Videos
Proteoglycans
Inborn Errors of Metabolism
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Pedigree Analysis
Lysosomal Hydrolases
Pleiotropy